GRAMD3 Inhibitors
GRAMD3 inhibitors encompass a diverse set of chemical entities that target various signaling pathways, leading to the downregulation of GRAMD3 activity. The inhibitory effects on GRAMD3 are achieved through mechanisms such as kinase inhibition, which disrupts multiple kinase-dependent signaling cascades that GRAMD3 may regulate. For instance, some inhibitors target the mTOR pathway, which is essential for cell growth and proliferation, thereby attenuating the processes that GRAMD3 is potentially involved in. Another mechanism is the inhibition of the PI3K/Akt pathway, a crucial signaling axis for cell survival and growth, which, when hindered, may reduce GRAMD3 activity if it is associated with this pathway. Similarly, inhibitors that block the MAPK/ERK pathway impede cellular proliferation and differentiation signals that could be linked to GRAMD3 function.
Moreover, the inhibition of protein kinase C (PKC) disrupts PKC-mediated signaling, potentially diminishing GRAMD3's activities related to this pathway. Given that PKC is involved in a multitude of cellular functions including the regulation of gene expression, cell cycle progression, and apoptosis, targeting this pathway could have wide-ranging effects on GRAMD3's role within these processes. Furthermore, chemical entities that interfere with calcium signaling may also impact GRAMD3's function, considering that calcium-dependent pathways are pivotal in various cellular responses. By altering calcium dynamics within the cell, these inhibitors could ultimately modulate GRAMD3's activity, especially if its function is calcium-sensitive.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A potent kinase inhibitor that targets a wide range of kinases thereby affecting various signaling pathways. It indirectly leads to the inhibition of GRAMD3 by disrupting kinase-dependent signaling cascades that GRAMD3 may be involved in regulating. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that impedes the mTOR pathway, which is crucial for cell growth and proliferation. This inhibition can attenuate the processes that GRAMD3 is potentially involved in, particularly if GRAMD3 function is related to cellular growth signals. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that hampers the PI3K/Akt pathway, a key signaling pathway for cell survival and growth. Inhibition of this pathway can lead to decreased activity of GRAMD3 if it is associated with PI3K/Akt signaling. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
An MEK inhibitor that blocks the MAPK/ERK pathway, which is implicated in cell proliferation and differentiation. Inhibiting this pathway can reduce GRAMD3 function if it is linked to MAPK/ERK signaling. | ||||||
Chelerythrine chloride | 3895-92-9 | sc-3547 sc-3547A | 5 mg 25 mg | $90.00 $317.00 | 17 | |
A selective inhibitor of protein kinase C (PKC) that disrupts PKC-mediated signaling. Given that PKC is involved in various cellular processes, the inhibition of PKC could lead to diminished GRAMD3 activity if GRAMD3 is involved in PKC-regulated pathways. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor that specifically blocks p38 MAPK signaling involved in inflammatory responses and stress. Inhibition of p38 MAPK could reduce the activity of GRAMD3 if it plays a role in p38 MAPK-regulated cellular responses. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
A selective inhibitor of MEK1/2, which prevents activation of MAPK/ERK signaling. By impeding this pathway, it can indirectly decrease GRAMD3 activity if GRAMD3 is part of ERK downstream signaling. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of c-Jun N-terminal kinase (JNK) that blocks JNK signaling pathways involved in apoptosis and cell differentiation. This could lead to inhibition of GRAMD3 function if GRAMD3 is coupled with JNK signaling. | ||||||
WZ 4002 | 1213269-23-8 | sc-364655 sc-364655A | 10 mg 50 mg | $180.00 $744.00 | 1 | |
An irreversible inhibitor of EGFR kinase activity, particularly mutant forms, that disrupts EGFR signaling. As EGFR pathways are essential in proliferation and survival, inhibiting them could indirectly inhibit GRAMD3 if it is associated with EGFR-mediated signaling. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor that prevents the degradation of proteins involved in cell cycle regulation and apoptosis. By inhibiting the proteasome, it could cause an accumulation of regulatory proteins that indirectly inhibit GRAMD3 if it is involved in proteasome-associated pathways. | ||||||